Literature DB >> 3397979

Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.

J G Llewellyn1, M H Pritchard.   

Abstract

In our study of 552 acute admissions for gastrointestinal hemorrhage, 18% were found to be taking nonsteroidal antiinflammatory drugs (NSAID) at the time of the bleed; 49% of these were found at endoscopy to have a gastric or prepyloric lesion, compared with 20% of the non-NSAID control group. Prescription data was used to calculate the risk added by age and disease state to the NSAID associated bleeding. We found that patients with chronic inflammatory disease had 2-3 times the expected bleeding incidence, but while there was a definite trend towards an age related risk in older patients, this was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397979

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Aging enhances susceptibility of diclofenac-treated rats to gastric ulceration, while attenuating enteropathy.

Authors:  C R Atchison; A Balakumaran; A B West; W E Hoffmann; M Treinen-Moslen
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 3.  [Risk of ulcer and its prophylaxis in therapy with non-steroidal antirheumatic drugs].

Authors:  L Köhler; W Mau; H Zeidler
Journal:  Med Klin (Munich)       Date:  1997-12-15

4.  Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat.

Authors:  S M Hinsull
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

5.  Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events.

Authors:  A E Voskuyl; M A Van de Laar; H J Moens; J K Van der Korst
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

Review 6.  Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Authors:  C H Wilder-Smith
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.